Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
02/08/1996 | CA2195980A1 Lock and key micelles |
02/08/1996 | CA2195748A1 Percutaneously absorbable preparation |
02/08/1996 | CA2195680A1 Incorporation of biologically active molecules into bioactive glasses |
02/08/1996 | CA2195639A1 Drug delivery composition for the nasal administration of antiviral agents |
02/08/1996 | CA2195629A1 Src sh3 binding peptides and methods of isolating and using same |
02/08/1996 | CA2195623A1 Self-emulsifying drug delivery system |
02/08/1996 | CA2194465A1 Process for preparing viruses and viral vectors |
02/07/1996 | EP0695760A1 Novel tumor marker for lung cancer |
02/07/1996 | EP0695551A2 Laxative composition containing a bulk laxative and a lubricating laxatif |
02/07/1996 | EP0695548A1 A stably storable and readily water soluble composition of cephalosporin for injections |
02/07/1996 | EP0695509A2 Liquid l-n-menthol composition and process for its preparation |
02/07/1996 | EP0695311A1 Cellulose binding domain |
02/07/1996 | EP0695195A1 Polymeric x-ray contrast compositions containing iodinated polymeric beads |
02/07/1996 | EP0695194A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates |
02/07/1996 | EP0695193A1 Transdermal active-substance preparation |
02/07/1996 | EP0695187A1 Compositions for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
02/07/1996 | EP0695186A1 Ocular delivery of nucleic acid |
02/07/1996 | EP0695182A1 Systems for controlled release of pilocarpine |
02/07/1996 | EP0695179A1 Transdermal antiinflammatory composition |
02/07/1996 | EP0695177A1 Active substance-containing plaster |
02/07/1996 | EP0695176A1 Solid form of administration of isosorbide 5-mononitrate |
02/07/1996 | EP0695175A1 Coated pharmaceutical compositions |
02/07/1996 | EP0695173A1 Manufacturing matrices |
02/07/1996 | EP0695170A1 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles |
02/07/1996 | EP0695169A1 Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use |
02/07/1996 | EP0695161A1 Cosmetic and medicinal topical preparations |
02/07/1996 | EP0686025A4 Titanium dioxide dispersions, cosmetic compositions and methods for using the same |
02/07/1996 | EP0580689B1 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material |
02/07/1996 | EP0499619B1 Method for producing protein microspheres |
02/07/1996 | EP0491921B1 Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance |
02/07/1996 | EP0470251B1 Liquid prostaglandin composition |
02/07/1996 | CN1116212A Prolonged release preparation and polymers thereof |
02/07/1996 | CN1116130A Magnetized solution |
02/07/1996 | CN1116119A Internal guide therapeutic medicine for rheumatoid disease and making method |
02/06/1996 | USRE35152 Administering detectably labeled immunoglobulin that accumulates at inflammation site |
02/06/1996 | US5489677 Nuclease resistant oligonucleotide analogs |
02/06/1996 | US5489615 Pharmaceutical ointment being free from skin irritative action and a process for the preparation thereof |
02/06/1996 | US5489577 Stabilized proteinaceous bioactive substance prepared by mixing with an oligosaccharide and kneading with an oil or fat base; ease of administration |
02/06/1996 | US5489525 Monoclonal antibodies to prostate cells |
02/06/1996 | US5489519 Multidrug resistance protein |
02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
02/06/1996 | US5489435 Composition for treatment of abnormal conditions of the epithelium of bodily orifices |
02/06/1996 | US5489425 Functionalized polyamine chelants |
02/06/1996 | US5489401 Method for entrapment of active materials in chitosan |
02/04/1996 | CA2155170A1 Stably storable and readily water soluble composition of cephalosporin for injections |
02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
02/01/1996 | WO1996002554A1 Dinucleoside-5',5'-pyrophosphates |
02/01/1996 | WO1996002488A1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
02/01/1996 | WO1996002278A1 Immunonanoparticles coated with anti-beta-2 microglobulin monoclonal antibodies |
02/01/1996 | WO1996002277A1 Solid drug forms containing clathrates of steroid sex hormones |
02/01/1996 | WO1996002276A2 Novel polymer gel networks and methods of use |
02/01/1996 | WO1996002265A1 The cellular basis of transplant arteriosclerosis |
02/01/1996 | WO1996002260A1 Wound healing agent |
02/01/1996 | WO1996002247A1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
02/01/1996 | WO1996002235A1 Injectable res avoiding inorganic particles |
02/01/1996 | WO1996002232A1 Composition and method for enhancing transdermal electrotransport agent delivery |
02/01/1996 | DE4427821A1 Stabilised super-paramagnetic aggregate particles |
02/01/1996 | DE4426429A1 Verfahren zum Einführen von DNA in höhere eukaryotische Zellen A method for introducing DNA into higher eukaryotic cells |
02/01/1996 | DE19527140A1 Sprühbare Lösungen mit blutdrucksenkender Wirkung und Verfahren zu ihrer Herstellung sowie ihre Verwendung Sprayable solutions with antihypertensive effect and process for their preparation and their use |
02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
02/01/1996 | CA2195091A1 Dinucleoside-5',5'-pyrophosphates |
02/01/1996 | CA2195072A1 Sustained-release oral ointment |
01/31/1996 | EP0694310A1 Reversible, thermally gelling water-base medicinal composition |
01/31/1996 | EP0694308A1 Cyclosporin-containing emulsion composition |
01/31/1996 | EP0694300A1 Treatment of impotence |
01/31/1996 | EP0693963A1 Use of a transacylation reaction between an esterified polysaccharide and a polyamine to form a membrane at least on the surface of gelled particles in an aqueous medium, resulting particles, preparation methods therefor and compositions containing same |
01/31/1996 | EP0693939A1 Nucleic acid tranfer peptides and their use for injecting nucleic acids into eucaryotic cells |
01/31/1996 | EP0693935A1 Method and compositions for digesting tissue |
01/31/1996 | EP0693926A1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
01/31/1996 | EP0693924A1 METHODS FOR $i(IN VIVO) DELIVERY OF BIOLOGICS AND COMPOSITIONS USEFUL THEREFOR |
01/31/1996 | EP0693922A1 Pharmaceutical composition containing lipophilic drugs |
01/31/1996 | EP0693921A1 Anti-oxidant alkylaryl polyether alcohol polymers |
01/31/1996 | EP0693904A1 Treated calcium/oxyanion-containing particles for medical diagnostic imaging |
01/31/1996 | EP0693878A1 Iodine barrier teat dip |
01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
01/31/1996 | EP0502119B1 Lipospheres for controlled delivery of substances |
01/31/1996 | CN2218579Y Medicine carrying film for curing periodontal, gingival and palatine mucosa diseases |
01/31/1996 | CN1115638A External-use drug form |
01/30/1996 | US5488126 Amino acid compounds for metal chelates |
01/30/1996 | US5488105 High molecular weight polysaccharides for foods |
01/30/1996 | US5488036 Gonadotrophins in cells for polypeptide hormones |
01/30/1996 | US5488034 Pharmaceutical composition comprising BPI proteins |
01/30/1996 | US5488029 Herbicidal N- [1,3,5-riazin-2-yl)-aminocarbonyl]-benzenesulfonamides |
01/30/1996 | US5487901 Coating with impermeable polymeric film; removal of raised top layer by contacting abraded surface with environment |
01/30/1996 | US5487900 Stabilized vitamin D preparation |
01/30/1996 | US5487898 Compositions and method for the sublingual or buccal administration therapeutic agents |
01/30/1996 | US5487897 Thermoplastic polymer, in vivo coagulation, drug delivery, wound healing, tissue regeneration |
01/30/1996 | US5487890 Mammalian primate erythrocyte bound heteropolymerized monoclonal antibodies and methods of use thereof |
01/30/1996 | CA2055905C Pharmaceutical composition comprising calcium polycarbophil |
01/30/1996 | CA2031572C Non-alcoholic delivery system for orally ingestible active ingredients |
01/30/1996 | CA2025078C External analgesic lotion and method of making |
01/30/1996 | CA1338008C Transdermal flux enhancing compositions |
01/28/1996 | CA2154745A1 Treatment of impotence |
01/25/1996 | WO1996001902A1 Adenovirus comprising a gene coding for an no synthase |
01/25/1996 | WO1996001874A1 Moisture barrier film coating composition, method, and coated form |
01/25/1996 | WO1996001863A1 Melt-processible poly(ester urethane) and a process for the preparation thereof |
01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |